Kai Ding
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- PARP inhibition in cancer therapy
Papers in
- Oncology 24
- Drug Transport and Resistance Mechanisms 11
- Co-authors
- Kathleen N. Moore (25 shared papers)Khondoker Alam (10 shared papers)Hua Fei (2 shared papers)Wei Yue (10 shared papers)Wenge Ding (1 shared paper)Alexandra Crowe (7 shared papers)Justin Dvorak (19 shared papers)Lang Li (3 shared papers)
- Journals
- Gynecologic Oncology (23 papers)Journal of Pharmaceutical Sciences (3 papers)Oncotarget (3 papers)Journal of Clinical Oncology (2 papers)Tobacco Control (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Kai Ding
116 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 136
- Internal Medicine 77
- Oncology 402
- Cancer Research 155
- Reproductive Medicine 84
- Ophthalmology 68
Countries citing papers authored by Kai Ding
This map shows the geographic impact of Kai Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Ding more than expected).
Fields of papers citing papers by Kai Ding
This network shows the impact of papers produced by Kai Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Ding. The network helps show where Kai Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 141 | |
| 2 | 2020 | 102 | |
| 3 | 2018 | 75 | |
| 4 | 2018 | 49 | |
| 5 | 2010 | 47 | |
| 6 | 2019 | 45 | |
| 7 | 2014 | 45 | |
| 8 | 2022 | 44 | |
| 9 | 2017 | 43 | |
| 10 | 2019 | 42 | |
| 11 | 2016 | 32 | |
| 12 | 2019 | 32 | |
| 13 | 2014 | 31 | |
| 14 | 2017 | 30 | |
| 15 | 2021 | 29 | |
| 16 | 2014 | 29 | |
| 17 | 2016 | 29 | |
| 18 | 2016 | 28 | |
| 19 | 2019 | 27 | |
| 20 | 2021 | 26 |
About Kai Ding
Kai Ding is a scholar working on Oncology, Molecular Biology, Physiology, Reproductive Medicine and Cancer Research, having authored 125 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (13 papers), Drug Transport and Resistance Mechanisms (11 papers), Smoking Behavior and Cessation (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers), HIV/AIDS drug development and treatment (6 papers), Endometrial and Cervical Cancer Treatments (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Statistical Methods and Bayesian Inference (5 papers). The work is most often cited by research in Internal Medicine (77 citations), Oncology (402 citations), Cancer Research (155 citations), Reproductive Medicine (84 citations) and Ophthalmology (68 citations). Kai Ding has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Kathleen N. Moore, Khondoker Alam, Hua Fei, Wei Yue, Wenge Ding, Alexandra Crowe, Justin Dvorak, Lang Li, Pengyue Zhang and Shailendra Kumar Dhar Dwivedi. Their work appears in journals such as Gynecologic Oncology, Journal of Pharmaceutical Sciences, Oncotarget, Journal of Clinical Oncology and Tobacco Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.